SpringWorks Therapeutics Announces Mirdametinib Data to be Presented at the 2024 Society for Neuro-Oncology (SNO) Annual Meeting
Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...
Future Market Insights4h
Pediatric Supplements Market Set to Reach USD 7,977.2 Million by 2034 with 8% CAGR Growth | Future Market Insights, Inc.
Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...
Sanofi’s Dupixent Gains EU Approval for Pediatric Eosinophilic Esophagitis
Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...
wahanariau3d
AskBio Receives FDA Rare Pediatric Disease and Orphan-Drug Designations for AB-1003 for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9
First patient dosed in Phase 1/Phase 2 LION-CS101 trial of AB-1003 in August 2023, with enrollment continuing; Askle ...
News Medical4d
UCD leads major EU project on extracellular vesicles for biomedical research
A major EU project coordinated from UCD is set to push the frontiers of biomedical research by exploring the transformative potential of extracellular vesicles (EVs).
PharmiWeb5d
Global Smart Wheelchair Market Poised for Impressive Growth, Expected to Reach USD 393.5 Million by 2034
The global smart wheelchair market is set for a period of significant expansion, with market projections indicating a striking increase from USD 185.7 million in 2024 to an estimated USD 393.5 million ...
PharmiWeb5d
Global Pediatric Clinical Trial Market Set for Remarkable Growth USD 31,661.0 million by 2034 as Demand for Child Health Solutions Surges | FMI
The global pediatric clinical trial market is poised for significant growth at a CAGR of 5.9% from 2024 to 2034. The global market size is projected to reach USD 17,918.1 million in 2024. By 2034, the ...